最新更新 :
28/04/2024
研究小組 - R&D Division, Biotechnology Research Institute, Celltrion   PDF  
韓國
製藥實驗室
R&D Division, Biotechnology Research Institute, Celltrion
Incheon
电子邮箱
引用文献   引用文献   (2)  
1
Investigation of the Physicochemical and Biological Stability of the Adalimumab Biosimilar CT-P17.
Kyeong Shin Y, Yong Han W, Jung Kim S, Woo Kim K, Won Ro J, Bin Lee J, Seok Oh J, Astier A. (YeonKyeong.Shin@celltrion.com)
Adv Ther - 2021 - ; 38 : 5609–5622
2
In-Use Physichochemical and Biological Stability of the Trastuzumab Biosimilar CT-P6 Upon Preparation for Intravenous Infusion.
Kim S.J, Lee J.W, Kang H.Y, Kim S.Y, Shin Y.K, Kim K.W, Oh J.S, Lim K.J, Kim J.Y. (SuJung.Kim@celltrion.com)
Bio Drugs - 2018 - 32;619-625

药品清单   分子研究   (2)  
免疫抑制剂 注射液 Adalimumab
抗癌藥物 注射液 Trastuzumab

  Mentions Légales